Eads & Heald Investment Counsel cut its position in C.R. Bard Inc. (NYSE:BCR) by 7.0% during the second quarter, Holdings Channel reports. The institutional investor owned 5,960 shares of the company’s stock after selling 446 shares during the period. Eads & Heald Investment Counsel’s holdings in C.R. Bard were worth $1,402,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Standard Life Investments LTD acquired a new position in C.R. Bard during the second quarter worth approximately $241,642,000. Panagora Asset Management Inc. boosted its position in C.R. Bard by 3.5% in the first quarter. Panagora Asset Management Inc. now owns 499,651 shares of the company’s stock worth $101,264,000 after buying an additional 17,012 shares in the last quarter. Smith Asset Management Group LP boosted its position in C.R. Bard by 32.4% in the second quarter. Smith Asset Management Group LP now owns 184,364 shares of the company’s stock worth $43,355,000 after buying an additional 45,083 shares in the last quarter. Squarepoint Ops LLC boosted its position in C.R. Bard by 49.4% in the first quarter. Squarepoint Ops LLC now owns 5,152 shares of the company’s stock worth $1,044,000 after buying an additional 1,703 shares in the last quarter. Finally, Silvercrest Asset Management Group LLC boosted its position in C.R. Bard by 30.3% in the first quarter. Silvercrest Asset Management Group LLC now owns 6,026 shares of the company’s stock worth $1,221,000 after buying an additional 1,401 shares in the last quarter. 87.90% of the stock is currently owned by institutional investors.
C.R. Bard Inc. (NYSE:BCR) traded up 2.59% during trading on Tuesday, hitting $224.71. The stock had a trading volume of 174,142 shares. The company has a market cap of $16.51 billion, a P/E ratio of 52.26 and a beta of 0.50. C.R. Bard Inc. has a one year low of $172.21 and a one year high of $239.43. The firm has a 50 day moving average of $222.37 and a 200-day moving average of $221.14.
C.R. Bard (NYSE:BCR) last announced its quarterly earnings data on Tuesday, July 26th. The company reported $2.54 EPS for the quarter, topping the Zacks’ consensus estimate of $2.47 by $0.07. C.R. Bard had a return on equity of 48.43% and a net margin of 9.20%. The firm had revenue of $931.50 million for the quarter, compared to the consensus estimate of $915.22 million. During the same quarter last year, the business posted $2.27 earnings per share. The firm’s revenue was up 8.3% compared to the same quarter last year. Equities analysts anticipate that C.R. Bard Inc. will post $10.17 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 4th. Shareholders of record on Monday, October 24th will be given a $0.26 dividend. The ex-dividend date is Thursday, October 20th. This represents a $1.04 dividend on an annualized basis and a yield of 0.47%. C.R. Bard’s dividend payout ratio is currently 24.24%.
BCR has been the topic of several recent research reports. Wells Fargo & Co. raised C.R. Bard from a “market perform” rating to an “outperform” rating in a report on Friday, September 16th. Bank of America Corp. cut C.R. Bard from a “buy” rating to a “neutral” rating in a report on Friday, July 8th. Jefferies Group reaffirmed a “hold” rating and set a $237.00 price objective on shares of C.R. Bard in a report on Tuesday, September 27th. Evercore ISI initiated coverage on C.R. Bard in a report on Thursday, September 15th. They set a “buy” rating and a $235.00 price objective on the stock. Finally, JPMorgan Chase & Co. upped their price objective on C.R. Bard from $214.00 to $225.00 and gave the stock a “neutral” rating in a report on Wednesday, July 27th. Thirteen equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $233.00.
In related news, Chairman Timothy M. Ring sold 92,293 shares of the business’s stock in a transaction on Wednesday, September 28th. The stock was sold at an average price of $227.81, for a total value of $21,025,268.33. Following the sale, the chairman now owns 145,876 shares in the company, valued at approximately $33,232,011.56. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Chairman Timothy M. Ring sold 110,000 shares of the business’s stock in a transaction on Monday, September 26th. The shares were sold at an average price of $228.96, for a total value of $25,185,600.00. Following the completion of the sale, the chairman now owns 96,030 shares in the company, valued at approximately $21,987,028.80. The disclosure for this sale can be found here. 0.97% of the stock is owned by company insiders.
About C.R. Bard
C. R. Bard, Inc (Bard) and its subsidiaries are engaged in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company sells its products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities.
Want to see what other hedge funds are holding BCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for C.R. Bard Inc. (NYSE:BCR).
Receive News & Ratings for C.R. Bard Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for C.R. Bard Inc. and related companies with MarketBeat.com's FREE daily email newsletter.